Dynavax Technologies (DVAX) EBIAT (2016 - 2025)
Historic EBIAT for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $26.9 million.
- Dynavax Technologies' EBIAT rose 5304.65% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.4 million, marking a year-over-year decrease of 31193.96%. This contributed to the annual value of $27.3 million for FY2024, which is 52743.78% up from last year.
- Dynavax Technologies' EBIAT amounted to $26.9 million in Q3 2025, which was up 5304.65% from $18.7 million recorded in Q2 2025.
- Over the past 5 years, Dynavax Technologies' EBIAT peaked at $128.8 million during Q2 2022, and registered a low of -$96.1 million during Q1 2025.
- Moreover, its 5-year median value for EBIAT was $11.4 million (2024), whereas its average is $17.9 million.
- In the last 5 years, Dynavax Technologies' EBIAT surged by 358787.88% in 2022 and then crashed by 100192.64% in 2025.
- Over the past 5 years, Dynavax Technologies' EBIAT (Quarter) stood at $99.8 million in 2021, then crashed by 32.12% to $67.7 million in 2022, then crashed by 99.68% to $219000.0 in 2023, then skyrocketed by 3119.18% to $7.0 million in 2024, then skyrocketed by 281.94% to $26.9 million in 2025.
- Its last three reported values are $26.9 million in Q3 2025, $18.7 million for Q2 2025, and -$96.1 million during Q1 2025.